Aurentz Vincent Insider Trades

Insider Trading History

Track insider trading activity for Aurentz Vincent. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $955k 510,596 shares
Last Trade
Feb 21, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$449k 255,299 shares
$1.76
$1.87
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $202k 108,176 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$211k 108,176 shares
$1.95
$1.87
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $251k 134,427 shares
Last Trade
Feb 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 134,427 shares
$2.97
$1.87
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $251k 134,427 shares
Last Trade
Feb 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 134,427 shares
$2.97
$1.87
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
Director
Holding Value $0 0 shares
Last Trade
Dec 02, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.27M 54,581 shares
$59.98
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
Director
Holding Value $1.35M 22,500 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$426k 22,500 shares
$18.94
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
Director
Holding Value $750k 12,500 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.3k 12,500 shares
$7.06
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
Director
Holding Value $742k 12,367 shares
Last Trade
May 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.4k 12,367 shares
$4.40
$59.98
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $2.81M 28,122 shares
Last Trade
Mar 11, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$5.6M 55,964 shares
$99.99
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $0 0 shares
Last Trade
Mar 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$41.6M 416,026 shares
$99.99
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $5.51M 55,122 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2M 21,462 shares
$93.19
$99.99
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
Director
Holding Value $742k 12,367 shares
Last Trade
Sep 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 19,581 shares
$9.10
$59.98
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $3.88M 38,850 shares
Last Trade
Mar 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.86M 60,710 shares
$80.08
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $9.5M 94,976 shares
Last Trade
Feb 16, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$210k 2,524 shares
$83.29
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $2.7M 27,000 shares
Last Trade
Feb 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$215k 2,524 shares
$85.00
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $2.95M 29,524 shares
Last Trade
Feb 16, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$210k 2,524 shares
$83.29
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $0 0 shares
Last Trade
Jan 07, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.4M 18,000 shares
$77.59
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $2.7M 27,000 shares
Last Trade
Jan 07, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.4M 18,000 shares
$77.59
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $900k 9,000 shares
Last Trade
Nov 25, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$590k 9,000 shares
$65.50
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CBO
Holding Value $1.8M 18,000 shares
Last Trade
Nov 25, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$590k 9,000 shares
$65.50
$99.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up